Our study is the first report on the prognostic relevance of MAPKBP1 expression in CN-AML, and demonstrates that MAPKBP1high is associated with shorter EFS and OS in CN-AML. This evidence concerns the gene MAPKBP1 and acute myeloid leukemia.